Armata Pharmaceuticals, Inc. has announced that it will hold its 2026 annual meeting of stockholders on June 11, 2026, at 8:30 a.m. Pacific Time. The meeting will take place at the company's principal executive offices located at 5005 McConnell Avenue, Los Angeles, California. Stockholders of record as of April 17, 2026, will be entitled to notice of the meeting and to vote on matters presented. Additionally, the deadline for stockholder proposals and director nominations is set for April 12, 2026, at 5:00 p.m. Pacific Time. Proposals must be submitted in writing to the Corporate Secretary at the company's address. This announcement is part of the company's compliance with SEC regulations and does not indicate any significant changes or events that would impact the stock price significantly.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.